A randomized, double-blind clinical study to determine the effect of ANKASCIN 568 plus on blood glucose regulation

Diabetes is the fourth major cause of death in Taiwan. High blood glucose can lead to macrovascular diseases, small vessel diseases (retinopathy, kidney disease), and neuropathy. This study aimed to investigate whether Monascus-fermented products (ANKASCIN 568 plus) can regulate blood glucose and bl...

Full description

Bibliographic Details
Main Authors: Yin-Ruei Wang, Sheng-Fu Liu, You-Cheng Shen, Chien-Li Chen, Chine-Ning Huang, Tzu-Ming Pan, Chin-Kun Wang
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Journal of Food and Drug Analysis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1021949816300953